Low Positivity Rate of Anti–SARS-CoV-2 IgG in Unvaccinated Patients With Rheumatic Diseases Treated With Rituximab : JCR: Journal of Clinical Rheumatology

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Concise Reports

Low Positivity Rate of Anti–SARS-CoV-2 IgG in Unvaccinated Patients With Rheumatic Diseases Treated With Rituximab

García-Fernández, Antía MD; Morán-Álvarez, Patricia MD; Bachiller-Corral, Javier MD; Vázquez-Díaz, Mónica MD

Author Information
JCR: Journal of Clinical Rheumatology: December 2022 - Volume 28 - Issue 8 - p 424-428
doi: 10.1097/RHU.0000000000001876
  • Buy
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.